Skip to content

Evaluation Genotypic, Phenotypic and Prognosis APECED Syndrome

Evaluation Genotypic, Phenotypic and Prognosis Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED) Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03751683
Acronym
APECED
Enrollment
29
Registered
2018-11-23
Start date
2009-07-30
Completion date
2018-01-25
Last updated
2025-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

APECED

Brief summary

The objective of the study will define the mutational spectrum in this French cohort, in patients with APECED syndrome genetically authenticated

Interventions

None listed

Sponsors

Ministry of Health, France
CollaboratorOTHER_GOV
University Hospital, Lille
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients with at least 2 major criteria out of the following 3: hypoparathyroidism of autoimmune origin, adrenal insufficiency of autoimmune origin, chronic cutaneous and mucosal candidiasis. * patients with only 1 of the 3 major criteria, associated with at least 2 of the following minor criteria: hypergonadotropic hypogonadism of autoimmune origin, atrophic gastritis, malabsorption, autoimmune hepatitis, vitiligo, alopecia, chronic keratoconjunctivitis, hypoplasia of dental enamel. * patients whose molecular diagnosis has been established or who will be established during the inclusion visit with the genetic sample.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
allelic frequency of the mutation c.967-979del13 of the AIRE geneBaseline: one session

Secondary

MeasureTime frame
total number of cases recognized APECED syndrome regardless of the diagnostic criteria used.Baseline: one session
correlations between the clinical phenotype and the autoantibodies on all cases with APECED syndrome.Baseline: one session
correlations between the mutations of the AIRE gene and the HLA genotyping on all cases with APECED syndrome.Baseline: one session
prevalence of types of antibodies found on APECED syndrome.Baseline: one session
the distribution of lymphocyte subpopulations on the whole cases with APECED syndrome.Baseline: one session
proportion of patients with a molecular diagnosis of positive APECED syndrome, among patients presenting our new diagnostic criteria (a major criterion and at least 2 criteriaBaseline: one session

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026